Back
NovaBay Pharmaceuticals Stock Price Chart
AI Marketing Is Moving Fast–Don't Miss Your Window!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
$0.59
Seasonality Move:
0.89%
7 Day Trial
ALL ACCESS PASS
$
7
Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.61 | Sell |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 0.89 | Sell |
| 8-day EMA: | 0.61 | Sell |
| 20-day EMA: | 0.62 | Sell |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 2.78 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.12 | Sell |
| Chaikin Money Flow: | -106486 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.63) | Sell |
| Bollinger Bands (100): | (0.58 - 0.7) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.59 while NBY 8-day simple moving average is 0.61, which is a Sell signal.
-
The stock price of NBY is 0.59 while NovaBay Pharmaceuticals 20-day SMA is 0.61, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.65 while NBY share price is 0.59, making it a Sell technically.
-
NBY stock price is 0.59 and NovaBay Pharmaceuticals 200-day simple moving average is 0.89, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.9M
Price in USD:
0.59
Share Volume:
106.5K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.59 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.59 while NBY 8-day exponential moving average is 0.61, which is a Sell signal.
-
The stock price of NBY is 0.59 while NovaBay Pharmaceuticals 20-day EMA is 0.62, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.63 while NBY share price is 0.59, making it a Sell technically.
-
NBY stock price is 0.59 and NovaBay Pharmaceuticals 200-day simple moving average is 2.78, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 42.12, which suggest NovaBay Pharmaceuticals is oversold
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.59 - 0.63), which suggest NovaBay Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.58 - 0.7), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.